Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke (RECOMBINE)

18. september 2017 opdateret af: Dr. med. Carlo Cereda

Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke to Increase Upper Limb Motor Recovery, a Randomised, Controlled, Double-blind Study

Rehabilitation after stroke improves motor functions by promoting plastic changes however, after completing standard rehabilitation, 50-60% of patients still exhibit some degree of motor impairment and require at least partial assistance in activities of day living. Therefore, the exploration of other approaches to promote recovery is compulsory. Non invasive brain stimulation and motor rehabilitation are thought to share similar mechanisms in inducing neuroplastic changes in the human cortex and an emerging field of research is focusing on the possibility of coupling both therapies in order to achieve an additive effect and improve outcome.

We hypothesize that coupling bihemispheric transcranial direct current stimulation (tDCS) with simultaneous physical/occupational therapy in the subacute phase of ischemic stroke patients may improve upper limb motor recovery in humans.

This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial. Thirty-six ischemic stroke patients in the subacute phase will be recruited in three centers of neurorehabilitation in Switzerland. After stratification based on the Fugl-Meyer Assessment Upper Extremity according to the severity of the deficit, the patient will be randomized to receive besides standardized physical/occupational treatment according to the Impairment-Oriented Training, tDCS of themotor cortex (1.5 mA, 30 minutes) (group 1: 12 patients) or sham stimulation (without current) (group 2: 12 patients). After three weeks of treatment group 1 and 2 will cross-over and will be treated for other three weeks. Group 3 (12 patients) will receive routine physical/occupational treatment and sham tDCS for six weeks. Assessment will be performed before starting tDCS, at week 3, 6 and at 6 months. Outcome measures are the Fugl-Meyer Assessment Upper Extremity, the extended Barthel Index, the Ashworth scale, the Test of Upper Limb Apraxia (only baseline, week 6, month6), the grip strength evaluated by the Jamar Hydraulic Hand dynamometer. At baseline at week 6 and at month 6 depression will be assessed by the Hamilton depression Rating Scale.

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

36

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

      • Bern, Schweiz, 3010
        • Trukket tilbage
        • Universitätsspital Bern, Inselspital, Neuropsychologische Rehabilitation
      • Brissago, Schweiz, 6614
        • Rekruttering
        • Clinica Hildebrand, Centro di riabilitazione Brissago
        • Kontakt:
        • Ledende efterforsker:
          • Paolo Rossi, MD
      • Zihlschlacht, Schweiz, 8588
        • Afsluttet
        • HELIOS Klinik Zihlschlacht AG, Neurologisches Rehabilitationszentrum

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  1. Ischemic lesions in the territory of middle cerebral artery subcortical or subcortical/cortical confirmed neuroimaging
  2. Inclusion must be in the sub-acute phase defined as within 2-4 weeks after stroke
  3. Persistent hemiparesis, indicated by a score of 1-3 on the motor arm item of the NIH Stroke Scale (NIHSS) (Brott et al. 1989) but wrist and finger movement is not required
  4. No UE injury or conditions that limited use prior to the stroke.
  5. The patient is >18 years old.
  6. The patient has subscribed the informed consent

Exclusion Criteria:

  1. History of epilepsy, brain tumor, major head trauma, learning disorder, severe cognitive impairment, drug or alcohol abuse, major psychiatric illness
  2. Use of medications that may lower seizure threshold (e.g., metronidazole, fluoroquinolones)
  3. Severe pain in the affected upper limb (>=8 on the shoulder item of the "joint pain during passive motion" of the Fugl-Meyer Assessment Upper Extremity)
  4. Further stroke or other significant medical complication during the study
  5. Evidence of severe leucoencephalopathy (grade IV according to the Fazeka's scale)
  6. Important aphasia that would impair the understanding and performance of the assessment scales

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Andet
  • Tildeling: Randomiseret
  • Interventionel model: Crossover opgave
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: 1 tDCS-Sham
tDC stimulation for 3 weeks, then cross-over to sham stimulation
Anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks, then sham stimulation for 30 seconds on 15 days during 3 weeks
Eksperimentel: 2 Sham-tDCS
Sham stimulation for 3 weeks, then cross over to tDCS stimulation
Sham stimulation for 30 seconds on 15 days during 3 weeks, then anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks
Sham-komparator: 3 Sham-Sham
Treatment for 6 weeks daily with sham stimulation
Sham stimulation for 30 seconds on 15 days during 6 weeks

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Fugl-Meyer Assessment Upper Extremity
Tidsramme: 6 weeks
Investigator administered questionnaire
6 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Fugl-Meyer Assessment Upper Extremity
Tidsramme: 3 weeks
Investigator administered questionnaire
3 weeks
Fugl-Meyer Assessment Upper Extremity
Tidsramme: 6 months
Investigator administered questionnaire
6 months
Barthel Index
Tidsramme: 3 weeks
Investigator administered questionnaire
3 weeks
Barthel Index
Tidsramme: 6 weeks
Investigator administered questionnaire
6 weeks
Barthel Index
Tidsramme: 6 months
Investigator administered questionnaire
6 months
Ashworth scale
Tidsramme: 3 weeks
Investigator administered questionnaire
3 weeks
Ashworth scale
Tidsramme: 6 weeks
Investigator administered questionnaire
6 weeks
Ashworth scale
Tidsramme: 6 months
Investigator administered questionnaire
6 months
Test of Upper Limb Apraxia (TULIA)
Tidsramme: 6 weeks
investigator administered questionnaire
6 weeks
Test of Upper Limb Apraxia (TULIA)
Tidsramme: 6 months
investigator administered questionnaire
6 months
Grip strength
Tidsramme: 3 weeks
Jamar Hydraulic Hand dynamometer
3 weeks
Grip strength
Tidsramme: 6 weeks
Jamar Hydraulic Hand dynamometer
6 weeks
Grip strength
Tidsramme: 6 months
Jamar Hydraulic Hand dynamometer
6 months
Hamilton depression Rating scale
Tidsramme: 6 weeks
Patient administered questionnaire
6 weeks
Hamilton depression Rating scale
Tidsramme: 6 months
Patient administered questionnaire
6 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Carlo Cereda, MD, Ospedale Regionale di Lugano - Civico

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. marts 2013

Primær færdiggørelse (Forventet)

1. februar 2018

Studieafslutning (Forventet)

1. februar 2018

Datoer for studieregistrering

Først indsendt

17. juli 2012

Først indsendt, der opfyldte QC-kriterier

17. juli 2012

Først opslået (Skøn)

19. juli 2012

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

19. september 2017

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

18. september 2017

Sidst verificeret

1. september 2017

Mere information

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med transcranial direct current stimulation (tDCS)

3
Abonner